CARLE EUREKA HOSPITAL — History
CCN 141309 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
+60.2%
Revenue CAGR (3yr)
-6.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $10M | $25M | $25M | -0.2% | +60.2% |
| Operating Expenses | $9M | $23M | $26M | +14.0% | +75.2% |
| Operating Margin | 11.4% | 7.1% | -6.0% | -184.4% | +0.0% |
| Net Income | $1M | $2M | $-1M | -184.3% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 865 | 2,283 | 2,058 | -9.9% | +54.2% |
| Medicare Day % | 49% | 54% | 58% | +8.9% | +9.4% |
| Medicaid Day % | nan% | nan% | 2% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +156.5% ($10M → $25M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+60.2%
This Hospital
+7.6%
State Avg
Latest Margin
-6.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $32M | -14.7% |
| FY2024 (proj) | $40M | -23.5% |
| FY2025 (proj) | $47M | -32.2% |